Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis

Chronic obstructive pulmonary disease (COPD) is a progressive disease that is characterized by a state of persistent inflammation and oxidative stress. The presence of oxidative stress in COPD is the result of an imbalance between pro-oxidant and antioxidant mechanisms. The aim of this review was to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elisabetta Zinellu, Angelo Zinellu, Maria Carmina Pau, Barbara Piras, Alessandro G. Fois, Sabrina Mellino, Ciriaco Carru, Arduino A. Mangoni, Pietro Pirina
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/5317ca2cc36d46c1ace45b0117ce040c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5317ca2cc36d46c1ace45b0117ce040c
record_format dspace
spelling oai:doaj.org-article:5317ca2cc36d46c1ace45b0117ce040c2021-11-25T16:27:42ZGlutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis10.3390/antiox101117452076-3921https://doaj.org/article/5317ca2cc36d46c1ace45b0117ce040c2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1745https://doaj.org/toc/2076-3921Chronic obstructive pulmonary disease (COPD) is a progressive disease that is characterized by a state of persistent inflammation and oxidative stress. The presence of oxidative stress in COPD is the result of an imbalance between pro-oxidant and antioxidant mechanisms. The aim of this review was to investigate a possible association between glutathione peroxidase (GPx), a key component of antioxidant defense mechanisms, and COPD. A systematic search for relevant studies was conducted in the electronic databases PubMed, Web of Science, Scopus, and Google Scholar, from inception to June 2021. Standardized mean differences (SMDs) were used to express the differences in GPx concentrations between COPD patients and non-COPD subjects. Twenty-four studies were identified. In 15 studies assessing whole blood/erythrocytes (GPx isoform 1), the pooled results showed that GPx concentrations were significantly lower in patients with COPD (SMD = −1.91, 95% CI −2.55 to −1.28, <i>p</i> < 0.001; moderate certainty of evidence). By contrast, in 10 studies assessing serum/plasma (GPx isoform 3), the pooled results showed that GPx concentrations were not significantly different between the two groups (very low certainty of evidence). The concentration of GPx-1, but not GPx-3, is significantly lower in COPD patients, suggesting an impairment of antioxidant defense mechanisms in this group.Elisabetta ZinelluAngelo ZinelluMaria Carmina PauBarbara PirasAlessandro G. FoisSabrina MellinoCiriaco CarruArduino A. MangoniPietro PirinaMDPI AGarticlechronic obstructive pulmonary diseaseoxidative stressantioxidant defense systemsglutathione peroxidaseTherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1745, p 1745 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic obstructive pulmonary disease
oxidative stress
antioxidant defense systems
glutathione peroxidase
Therapeutics. Pharmacology
RM1-950
spellingShingle chronic obstructive pulmonary disease
oxidative stress
antioxidant defense systems
glutathione peroxidase
Therapeutics. Pharmacology
RM1-950
Elisabetta Zinellu
Angelo Zinellu
Maria Carmina Pau
Barbara Piras
Alessandro G. Fois
Sabrina Mellino
Ciriaco Carru
Arduino A. Mangoni
Pietro Pirina
Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
description Chronic obstructive pulmonary disease (COPD) is a progressive disease that is characterized by a state of persistent inflammation and oxidative stress. The presence of oxidative stress in COPD is the result of an imbalance between pro-oxidant and antioxidant mechanisms. The aim of this review was to investigate a possible association between glutathione peroxidase (GPx), a key component of antioxidant defense mechanisms, and COPD. A systematic search for relevant studies was conducted in the electronic databases PubMed, Web of Science, Scopus, and Google Scholar, from inception to June 2021. Standardized mean differences (SMDs) were used to express the differences in GPx concentrations between COPD patients and non-COPD subjects. Twenty-four studies were identified. In 15 studies assessing whole blood/erythrocytes (GPx isoform 1), the pooled results showed that GPx concentrations were significantly lower in patients with COPD (SMD = −1.91, 95% CI −2.55 to −1.28, <i>p</i> < 0.001; moderate certainty of evidence). By contrast, in 10 studies assessing serum/plasma (GPx isoform 3), the pooled results showed that GPx concentrations were not significantly different between the two groups (very low certainty of evidence). The concentration of GPx-1, but not GPx-3, is significantly lower in COPD patients, suggesting an impairment of antioxidant defense mechanisms in this group.
format article
author Elisabetta Zinellu
Angelo Zinellu
Maria Carmina Pau
Barbara Piras
Alessandro G. Fois
Sabrina Mellino
Ciriaco Carru
Arduino A. Mangoni
Pietro Pirina
author_facet Elisabetta Zinellu
Angelo Zinellu
Maria Carmina Pau
Barbara Piras
Alessandro G. Fois
Sabrina Mellino
Ciriaco Carru
Arduino A. Mangoni
Pietro Pirina
author_sort Elisabetta Zinellu
title Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
title_short Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
title_full Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
title_fullStr Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
title_full_unstemmed Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
title_sort glutathione peroxidase in stable chronic obstructive pulmonary disease: a systematic review and meta-analysis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/5317ca2cc36d46c1ace45b0117ce040c
work_keys_str_mv AT elisabettazinellu glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT angelozinellu glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT mariacarminapau glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT barbarapiras glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT alessandrogfois glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT sabrinamellino glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT ciriacocarru glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT arduinoamangoni glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
AT pietropirina glutathioneperoxidaseinstablechronicobstructivepulmonarydiseaseasystematicreviewandmetaanalysis
_version_ 1718413135435530240